This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents. Top assignee: Taiyo Kagaku Co., Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Takeo Yokawa: Innovator in Bowel Disease Treatment
Introduction
Takeo Yokawa is a notable inventor based in Yokkaichi, Japan. He has made significant contributions to the field of medical compositions aimed at treating bowel diseases. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Yokawa holds a patent for an "Enteropathy ameliorating composition." This invention relates to a composition designed for preventing, ameliorating, or treating bowel diseases. The composition includes galactomannan and/or arabinogalactan, which are key ingredients in promoting gut health. Additionally, he has developed a liquid food formulation that combines protein with galactomannan and/or arabinogalactan for the same therapeutic purposes. Furthermore, his patent includes a composition specifically aimed at preventing, ameliorating, or treating irritable bowel syndrome, utilizing degraded galactomannan as a primary component. He has 1 patent to his name.
Career Highlights
Yokawa is associated with Taiyo Kagaku Co., Ltd., a company known for its focus on innovative health solutions. His work at the company has allowed him to explore and develop new treatments that can significantly improve the quality of life for individuals suffering from bowel diseases.
Collaborations
Throughout his career, Yokawa has collaborated with esteemed colleagues such as Noriyuki Ishihara and Nobuhiko Aoyama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Takeo Yokawa's contributions to the field of bowel disease treatment through his innovative patent demonstrate his commitment to improving health outcomes. His work continues to inspire advancements in medical compositions aimed at enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile